Table 5 Postsurgical recurrence

From: Ten-year follow-up results of a randomised controlled study comparing level-I vs level-III axillary lymph node dissection for primary breast cancer

 

Group-A (level-III), n =258

Group-B (level-I), n =256

Statistics

Recurrence

53 (20.55%)

58 (22.65%)

NS

Primary recurrent site

   

 Local recurrence

15 (5.81)

13 (5.08%)

 

 Contralateral breast

0 (0%)

1 (0.39%)

 

 Nodal metastasis

18 (6.98%)

16 (6.25%)

 

Axillary

0 (0%)

1 (0.39%)

NS

Contralateral axillary

1 (0.39%)

0 (0%)

 

Supraclavicular

15 (5.81%)

15 (5.86%)

 

Parasternal

2 (0.78%)

0 (0%)

 

 Distant metastasis

20 (7.8%)

28 (10.9%)

NS

Bone

8 (3.10%)

11 (4.30%)

 

Lung

7 (2.71%)

10 (3.91%)

 

Liver

3 (1.16%)

5 (1.95%)

 

Others

2 (0.78%)

2 (0.78%)

 

Death due to

   

 Breast cancer

24 (9.30%)

29 (11.33%)

NS

 Other diseases

6 (2.33%)

6 (2.35%)

 
  1. NS=no significant difference.
Back to article page